Just on the quality of the medications. As Richard has said, the bioequivalency of these drugs needs to be identical to what we have available to us here in Canada. The thing that we have when we're dealing with partners in Africa, now that we know that.... There's a great deal of trust in terms of the system that we presently have in place to ensure that quality, in comparison to the trust that there may be for the other drugs that are arriving to market today.
On October 21st, 2010. See this statement in context.